Michael Maschio
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
-
- SARS-CoV-2 and COVID-19 Research 8
-
- Influenza Virus Research Studies 7
- Pneumonia and Respiratory Infections 3
- Respiratory viral infections research 3
- Co-authors
- Milton C. Weinstein (14 shared papers)Michele Kohli (16 shared papers)Debbie Becker (4 shared papers)Michael Drummond (5 shared papers)Ayman Chit (2 shared papers)Carlos A. DiazGranados (2 shared papers)J Mould-Quevedo (3 shared papers)Shannon Cartier (2 shared papers)
- Journals
- Journal of Medical Economics (5 papers)Value in Health (5 papers)Vaccines (4 papers)PharmacoEconomics (3 papers)Human Vaccines & Immunotherapeutics (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Michael Maschio
29 papers receiving 403 citations
Peers
Comparison fields: 5 of 49
- Modeling and Simulation 43
- Health 59
- Infectious Diseases 90
- Epidemiology 115
- Cardiology and Cardiovascular Medicine 59
Countries citing papers authored by Michael Maschio
This map shows the geographic impact of Michael Maschio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Maschio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Maschio more than expected).
Fields of papers citing papers by Michael Maschio
This network shows the impact of papers produced by Michael Maschio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Maschio. The network helps show where Michael Maschio may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Maschio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 101 | |
| 2 | 2009 | 60 | |
| 3 | 2015 | 35 | |
| 4 | 2013 | 31 | |
| 5 | 2016 | 24 | |
| 6 | 2011 | 21 | |
| 7 | 2023 | 16 | |
| 8 | 2021 | 16 | |
| 9 | 2016 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2021 | 10 | |
| 12 | 2009 | 10 | |
| 13 | 2023 | 9 | |
| 14 | 2014 | 8 | |
| 15 | 2015 | 6 | |
| 16 | 2022 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2018 | 4 | |
| 19 | 2017 | 4 | |
| 20 | 2020 | 3 |
About Michael Maschio
Michael Maschio is a scholar working on Infectious Diseases, Epidemiology, Oncology, Health and Economics and Econometrics, having authored 31 papers that have together received 411 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Influenza Virus Research Studies (7 papers), Vaccine Coverage and Hesitancy (6 papers), Neutropenia and Cancer Infections (5 papers), Pneumonia and Respiratory Infections (3 papers), Respiratory viral infections research (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Economic and Financial Impacts of Cancer (3 papers). The work is most often cited by research in Modeling and Simulation (43 citations), Health (59 citations), Infectious Diseases (90 citations), Epidemiology (115 citations) and Cardiology and Cardiovascular Medicine (59 citations). Michael Maschio has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Milton C. Weinstein, Michele Kohli, Debbie Becker, Michael Drummond, Ayman Chit, Carlos A. DiazGranados, J Mould-Quevedo, Shannon Cartier, Deborah A. Marshall and Hein Heidbüchel. Their work appears in journals such as Journal of Medical Economics, Value in Health, Vaccines, PharmacoEconomics and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.